| Dissociable intrinsic connectivity networks for salience processing and executive control WW Seeley, V Menon, AF Schatzberg, J Keller, GH Glover, H Kenna, ... Journal of neuroscience 27 (9), 2349-2356, 2007 | 8006 | 2007 |
| Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus MD Greicius, BH Flores, V Menon, GH Glover, HB Solvason, H Kenna, ... Biological psychiatry 62 (5), 429-437, 2007 | 2677 | 2007 |
| Psychiatric complications of treatment with corticosteroids: review with case report HA Kenna, AW Poon, CP de los Angeles, LM Koran Psychiatry and clinical neurosciences 65 (6), 549-560, 2011 | 341 | 2011 |
| Cortisol circadian rhythm alterations in psychotic major depression J Keller, B Flores, RG Gomez, HB Solvason, H Kenna, GH Williams, ... Biological psychiatry 60 (3), 275-281, 2006 | 285 | 2006 |
| Clinical and biological effects of mifepristone treatment for psychotic depression BH Flores, H Kenna, J Keller, HB Solvason, AF Schatzberg Neuropsychopharmacology 31 (3), 628-636, 2006 | 264 | 2006 |
| Preliminary evidence that plasma oxytocin levels are elevated in major depression KJ Parker, HA Kenna, JM Zeitzer, J Keller, CM Blasey, JA Amico, ... Psychiatry research 178 (2), 359-362, 2010 | 202 | 2010 |
| Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease NL Rasgon, HA Kenna, TE Wroolie, R Kelley, D Silverman, J Brooks, ... Neurobiology of aging 32 (11), 1942-1948, 2011 | 196 | 2011 |
| The neuropsychological profile of psychotic major depression and its relation to cortisol RG Gomez, SH Fleming, J Keller, B Flores, H Kenna, C DeBattista, ... Biological psychiatry 60 (5), 472-478, 2006 | 181 | 2006 |
| Rosiglitazone add‐on in treatment of depressed patients with insulin resistance: a pilot study NL Rasgon, HA Kenna, KE Williams, B Powers, T Wroolie, AF Schatzberg The Scientific World Journal 10 (1), 321-328, 2010 | 121 | 2010 |
| Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol KW Yuen, JP Garner, DS Carson, J Keller, A Lembke, SA Hyde, ... Journal of psychiatric research 51, 30-36, 2014 | 117 | 2014 |
| Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline J Lin, CH Kroenke, E Epel, HA Kenna, OM Wolkowitz, E Blackburn, ... Brain research 1379, 224-231, 2011 | 112 | 2011 |
| Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD DHS Silverman, CL Geist, HA Kenna, K Williams, T Wroolie, B Powers, ... Psychoneuroendocrinology 36 (4), 502-513, 2011 | 107 | 2011 |
| Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? RS McIntyre, HA Kenna, HT Nguyen, CWY Law, F Sultan, ... Advances in therapy 27, 63-80, 2010 | 102 | 2010 |
| Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis NL Rasgon, HA Kenna Neurobiology of aging 26 (1), 103-107, 2005 | 92 | 2005 |
| Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens TE Wroolie, HA Kenna, KE Williams, BN Powers, M Holcomb, A Khaylis, ... The American Journal of Geriatric Psychiatry 19 (9), 792-802, 2011 | 90 | 2011 |
| Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia NL Rasgon, CL Geist, HA Kenna, TE Wroolie, KE Williams, ... PloS one 9 (3), e89095, 2014 | 85 | 2014 |
| Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease H Kenna, F Hoeft, R Kelley, T Wroolie, B DeMuth, A Reiss, N Rasgon Neurobiology of aging 34 (3), 641-649, 2013 | 79 | 2013 |
| Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use EG Jacobs, C Kroenke, J Lin, ES Epel, HA Kenna, EH Blackburn, ... PloS one 8 (2), e54713, 2013 | 79 | 2013 |
| Mood and neuropsychological changes in women with midlife depression treated with escitalopram TE Wroolie, KE Williams, J Keller, LN Zappert, SD Shelton, HA Kenna, ... Journal of Clinical Psychopharmacology 26 (4), 361-366, 2006 | 77 | 2006 |
| Decreased hypothalamic functional connectivity with subgenual cortex in psychotic major depression K Sudheimer, J Keller, R Gomez, L Tennakoon, A Reiss, A Garrett, ... Neuropsychopharmacology 40 (4), 849-860, 2015 | 60 | 2015 |
